-
Ennature Biopharma is the natural ingredients division of India Glycols, set up in 2009 to leverage the India Glycols expertise in advanced green technologies and to develop high quality, plant-based ingredients for the pharmaceutical and nutraceutical industries
-
India Glycols is a USD 750 million listed, global leader in specialty, bio-based, chemicals since 1984
-
India Glycols has been a pioneer of green technologies and holds the distinction of being the first and only company in the world to commercialize the production of ethylene oxide and glycols from renewable agricultural feedstocks
Who We Are
-
At Ennature Biopharma, we develop, and manufacture value-added, plant-based ingredients for pharmaceutical, nutraceutical, and food and beverage industries
-
We source our raw materials mainly from India, with strong partnerships, and farmer connect to ensure the sustainability and quality at the source
-
We use 100% green SCF- CO₂ technology to manufacture our nutraceutical actives and have an exceptionally strong manufacturing and green technology base
-
We hold a leadership position in the manufacture of high value plant-based phytochemicals (API’s)
What We Do
Our Strengths
Diverse Manufacturing Facilities
International Accreditations
Strong
Quality Focus
Green
Innovation
Global
Presence
Purpose
We deliver incredible natural solutions for healthy living
Our Values
Excellence
Collaboration
Innovation
Care
We are pioneers of green technology and strongly integrate sustainability initiatives into each aspect of our operations.
-
Use of Green CO₂ and Ethanol for Manufacturing: We use in-house suagrcane based ‘green’ CO₂ and ethanol as clean extraction solvents for manufacturing high value nutraceutical ingredients and recycle all our solvents to make sure our products and processes are entirely sustainable
-
Zero Solid and Liquid Discharge System: We recycle and reuse all our water and treat 100% of our effluent water discharged from all our manufacturing activities
-
Energy from Waste Biomass: We convert all our plant residue post extraction into biomass briquettes and use it as fuel for our boiler. We proudly generate over 70% of our fuel requirement through such initiatives
Our Sustainability Initiatives
.jpg)
Milestones
From a Small Beginning to Transformation, Diversification and Growth!
Getting Started
2008-2013
-
Manufacturing facility commissioned at Pharmacity, Dehradun with a state-of-the-art SCF CO₂ plant, solvent refining and aqueous extraction facility
-
Strategic tie-up for manufacturing of high value Astaxanthin by SCF –CO₂ extraction
-
Manufacturing initiated for high-value Thiocolchicoside API and other API ingredients
-
Formulation plant started for converting nutraceutical extracts to oleoresins, powders and beadlets
Developing Depth, Expertise and Leadership
2014-2019
-
Established leadership in Thiocolchicoside API and achieved highest export volumes for Thiocolchicoside globally
-
Granted US patent for “Single phase Lutein Ester extraction from tagetes species: Marigold flower meal”
-
Commissioned new plant for production of Nicotine API as a key portfolio expansion
Adding new Dimensions
2020-2023
-
Expansion of Nicotine facility to meet the growing demand for Nicotine API
-
Launch of first branded nutraceutical ingredient – MAXICUMA® and LIMAN™ technology platform for converting lipophilic extracts into water-soluble powders
-
Launch of SCEMOD™ technology and other branded nutraceutical ingredients range
-
Successful passing of the EU-GMP sitewide audit by the edqm audit and CEP certification for Thiocolchicoside and Colchicine API’s